Researchers at Stanford University have identified molecular regulators that can act as part of a personalized treatment plan to help treat hormone-related conditions, including pregnancy and infertility.
Histone acetyltransferase 1 (HAT1) is an enzyme which acetylates lysine on histone proteins and is intricately involved with regulating gene transcription.